Arvinas (ARVN) FCF Margin Growth (3y) (2020 - 2026)
Arvinas (ARVN) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-15,959.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-15,959.00 |
| Dec 31, 2025 |
-13,427.00 |
| Sep 30, 2025 |
5,871.00 |
| Jun 30, 2025 |
-19,886.00 |
| Mar 31, 2025 |
16,871.00 |
| Dec 31, 2024 |
-2,118.00 |
| Sep 30, 2024 |
-746,869.00 |
| Jun 30, 2024 |
95,198.00 |
| Mar 31, 2024 |
32,553.00 |
| Dec 31, 2023 |
58,010.00 |
| Sep 30, 2023 |
6,114.00 |
| Jun 30, 2023 |
25,979.00 |
| Mar 31, 2023 |
-633.00 |
| Dec 31, 2022 |
26,817.00 |
| Sep 30, 2022 |
-21,658.00 |
| Jun 30, 2022 |
17,276.00 |
| Mar 31, 2022 |
11,385.00 |
| Dec 31, 2021 |
23,009.00 |
| Sep 30, 2021 |
767,807.00 |
| Jun 30, 2021 |
-52,915.00 |
